Gilead Sciences

Finweek English Edition - - COVER -

Bio­phar­ma­ceu­ti­cal company with a fo­cus on de­vel­op­ing medicines in ar­eas of un­met med­i­cal need, in­clud­ing HIV/ Aids, can­cer and liver dis­ease.

Mar­ket cap: $171.5m

Newspapers in English

Newspapers from South Africa

© PressReader. All rights reserved.